Announcement XORTX Therapeutics Inc., a leading late-stage clinical pharmaceutical company aiming to establish innovative therapies for the treatment of progressive kidney and gout diseases, unveiled the latest independent peer-reviewed published research reports. The reports that extend recent inf...
Announcement Cogent Biosciences, Inc., a leading biotechnology company dedicated to establishing accurate therapies for genetically defined diseases, has now submitted its promising New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the company’s best-in-class bezuc...
Recap Tiger BioSciences spotlights the number of important and valuable scientific and clinical advances that have been made from the company’s extensive investment in proof-based research across this year. This smart and rock-built strategy target has bolstered the company’s position a...
Announcement Autonomix Medical, Inc., a known medical device company devoted to modernising the accurate nerve-focused treatments, have received an official patent right from the European Patent Office (EPO) with the Patent No. EP4230133 with the title ‘Controlled and Precise Treatment of Car...
Announcement Sinopia Biosciences, Inc., a leading biotechnology company known for modernising novel therapeutics with the help of its exclusive LEADS® drug discovery platform, proudly declared their platform has been rewarded. The financial reward from the National Institute of General Medical ...
Announcement Johnson & Johnson, the popular company, has completed its acquisition of Halda Therapeutics OpCo, Inc., a known clinical-level biotechnology company. Along with this acquisition, Johnson & Johnson will now have the authority to use Halda’s exclusive Regulated Induced Prox...
Announcement SELLAS Life Sciences Group, Inc., a leading late-stage clinical biopharmaceutical company focused on the establishment of novel therapies for a wide range of cancer indications have an update to announce for its ongoing Phase 3 REGAL trial. The trial assessed GPS as a capable maintenan...
Announcement Co-Diagnostics, Inc., a leading molecular diagnostics company with a remarkable patented platform for the establishment of molecular diagnostics tests, today proudly announced that it has received a patent right from the Australian Patent Office. The Australian Patent No. AU2022270084A...
Announcement WORK Medical Technology Group LTD, a well-known provider of medical devices in China, operates via its branch named Work (Hangzhou) Medical Treatment Equipment Co., Ltd and its other branches in China have announced an approval. An approval to its branch, Hunan Saitumofei Co., Ltd, to ...
Announcement Caliway, a leading biopharmaceutical company, proudly announced its submission of an Investigational New Drug (IND) application to the US FDA for its robust Phase 2 clinical study of its first-ever step in a vast localised fat reduction drug candidate. The candidate for CBL-514 for the...
